Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.29 trillion and total revenue of $115.73 billion.
Market Cap
1.29T
Revenue
115.73B
Profits
-39.37B
PE Ratio
n/a
Profit Margin
-34.02%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 128.19B | -2.07% | 1,130,474 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.23B | -0.31% | 425,601 | 15.53B |
| 3 | ARGX | argenx SE | 52.87B | -0.66% | 278,668 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 43.66B | 0.85% | 783,848 | - |
| 5 | ONC | BeOne Medicines AG | 39.51B | -2.40% | 382,856 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.70B | 0.47% | 1,596,476 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.60B | 0.67% | 1,525,906 | 4.80B |
| 8 | INSM | Insmed Incorporated | 27.02B | -2.05% | 1,957,223 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.15B | -0.22% | 4,527,331 | 7.53M |
| 10 | MRNA | Moderna, Inc. | 25.28B | -0.52% | 4,700,892 | 2.23B |
| 11 | INCY | Incyte Corporation | 24.36B | -0.30% | 785,740 | 5.82B |
| 12 | BNTX | BioNTech SE | 23.38B | 1.05% | 649,509 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.75B | 1.91% | 3,427,175 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.32B | 0.92% | 650,345 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.90B | -0.36% | 542,036 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.61B | -1.66% | 3,094,030 | 713.07M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.04B | -1.74% | 1,413,468 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 12.70B | 1.24% | 2,342,499 | 2.44B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.37B | 3.58% | 728,887 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.24B | 1.23% | 817,969 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | 0.04% | 234,655 | 1.28B |
| 22 | TECH | Bio-Techne Corporation | 11.28B | 0.32% | 2,013,951 | 1.22B |
| 23 | HALO | Halozyme Therapeutics, Inc. | 11.20B | -2.00% | 1,659,273 | 1.66B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.19B | - | 476,320 | 776.57M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.65B | -4.64% | 9,748,872 | - |
| 26 | CYTK | Cytokinetics, Incorporated | 10.31B | 0.93% | 1,756,858 | 67.67M |
| 27 | ABVX | ABIVAX Société Anonyme | 10.25B | -2.05% | 899,745 | 5.67M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.24B | -0.45% | 262,229 | 7.46M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.15B | 0.07% | 1,479,754 | - |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 10.04B | 2.43% | 426,255 | 281.99M |
| 31 | KRYS | Krystal Biotech, Inc. | 9.83B | 1.20% | 167,863 | 440.48M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.76B | 2.60% | 468,580 | 105.00M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.51B | 2.45% | 1,353,685 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.14B | 1.75% | 559,226 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.31% | 2,279,040 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.64B | -1.34% | 656,558 | - |
| 37 | IMVT | Immunovant, Inc. | 8.64B | - | 722,452 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.02B | -1.05% | 4,912,668 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | -0.47% | 334,852 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.35B | 2.70% | 1,047,249 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 6.91B | 1.67% | 1,073,261 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.65B | 0.43% | 596,273 | 6.23M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.58B | 1.66% | 1,228,827 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 1.89% | 503,768 | 618.07M |
| 45 | DNTH | Dianthus Therapeutics, Inc. | 6.49B | 5.80% | 903,323 | 1.90M |
| 46 | ERAS | Erasca, Inc. | 6.43B | 2.91% | 2,465,949 | - |
| 47 | BLTE | Belite Bio, Inc | 6.40B | -2.09% | 228,799 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 6.40B | -1.02% | 496,596 | - |
| 49 | CAI | Caris Life Sciences, Inc. | 6.16B | -1.71% | 3,868,841 | 989.61M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 6.04B | -2.93% | 921,774 | 7.50M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.98B | -0.38% | 564,330 | 1.01B |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 2.00% | 197,207 | 290.54M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.86B | 1.16% | 1,190,556 | 591.33M |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.73B | -2.89% | 1,709,482 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 5.18B | -0.81% | 807,994 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.87B | -0.49% | 1,062,474 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.80B | -1.00% | 1,684,452 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | 2.29% | 779,888 | - |
| 59 | PBLS | Parabilis Medicines, Inc. | 4.72B | 3.92% | 290,893 | - |
| 60 | MANE | Veradermics, Incorporated | 4.71B | 1.54% | 523,467 | - |
| 61 | CELC | Celcuity Inc. | 4.50B | 6.24% | 1,333,508 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.35B | -0.35% | 1,530,218 | 10.35M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.32B | -0.19% | 1,439,357 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 4.31B | 1.31% | 350,220 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 4.03B | -4.14% | 120,674 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.94B | 0.49% | 2,017,451 | 1.27B |
| 67 | DNLI | Denali Therapeutics Inc. | 3.90B | -1.69% | 889,993 | 3.60M |
| 68 | GPCR | Structure Therapeutics Inc. | 3.89B | -0.35% | 555,889 | - |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.87B | 0.76% | 1,180,618 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.75B | 2.15% | 1,150,675 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.69B | 3.74% | 12,375,083 | 66.17M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | -1.04% | 434,977 | 234.13M |
| 73 | QURE | uniQure N.V. | 3.37B | 3.31% | 957,617 | 18.67M |
| 74 | MBX | MBX Biosciences, Inc. | 3.30B | 2.22% | 503,134 | - |
| 75 | CLDX | Celldex Therapeutics, Inc. | 3.29B | -1.55% | 849,360 | 158.00K |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | 1.39% | 1,109,468 | 463.98M |
| 77 | ALMS | Alumis Inc. | 3.28B | 3.69% | 1,217,186 | 7.40M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | 1.16% | 959,578 | 7.12M |
| 79 | IOVA | Iovance Biotherapeutics, Inc. | 3.16B | 7.06% | 17,507,568 | 324.97M |
| 80 | IMNM | Immunome, Inc. | 3.09B | 2.95% | 760,763 | 4.02M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 0.46% | 448,239 | 606.33M |
| 82 | IRON | Disc Medicine, Inc. | 3.03B | -1.46% | 262,504 | - |
| 83 | ZLAB | Zai Lab Limited | 2.91B | -0.50% | 1,234,001 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -0.51% | 738,504 | 36.77M |
| 85 | ATAI | AtaiBeckley Inc. | 2.69B | 0.14% | 6,100,062 | 4.47M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.67B | 0.91% | 1,229,787 | 156.04M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 1.71% | 1,389,735 | - |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 0.42% | 1,222,222 | 717.00M |
| 89 | KOD | Kodiak Sciences Inc. | 2.59B | 3.43% | 746,902 | - |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.58B | 3.40% | 4,412,824 | - |
| 91 | COAG | Hemab Therapeutics Holdings, Inc. | 2.57B | 1.84% | 101,166 | - |
| 92 | VRDN | Viridian Therapeutics, Inc. | 2.50B | 0.41% | 1,093,186 | 71.13M |
| 93 | NKTR | Nektar Therapeutics | 2.49B | -3.82% | 827,910 | 54.59M |
| 94 | PHVS | Pharvaris N.V. | 2.47B | 3.23% | 862,849 | - |
| 95 | URGN | UroGen Pharma Ltd. | 2.36B | 0.21% | 458,056 | 188.73M |
| 96 | KLRA | Kailera Therapeutics, Inc. | 2.33B | -0.17% | 335,982 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 2.28B | 9.48% | 5,873,977 | - |
| 98 | RAPP | Rapport Therapeutics, Inc. | 2.28B | 0.13% | 159,830 | 20.00M |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -1.72% | 697,736 | - |
| 100 | VCEL | Vericel Corporation | 2.26B | -0.76% | 276,053 | 306.30M |
| 101 | PVLA | Palvella Therapeutics, Inc. | 2.25B | -0.27% | 109,814 | - |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | -0.99% | 388,564 | 959.90M |
| 103 | BHVN | Biohaven Ltd. | 2.21B | -1.41% | 1,244,134 | - |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.20B | -0.59% | 1,634,134 | 52.06M |
| 105 | PGEN | Precigen, Inc. | 2.18B | -6.01% | 7,960,237 | 85.72M |
| 106 | NUVB | Nuvation Bio Inc. | 2.18B | 1.97% | 13,326,985 | 169.90M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.12B | 0.64% | 1,308,515 | 512.28M |
| 108 | SEPN | Septerna, Inc. | 2.08B | -1.42% | 630,342 | 98.88M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.91% | 827,250 | 311.51M |
| 110 | MESO | Mesoblast Limited | 2.04B | -5.43% | 164,754 | 65.38M |
| 111 | GHRS | GH Research PLC | 2.02B | 4.61% | 233,831 | - |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.13% | 495,115 | 27.59M |
| 113 | GENB | Generate Biomedicines, Inc. | 2.01B | 4.06% | 310,803 | 26.48M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 0.27% | 1,124,468 | 98.34M |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.94B | -0.67% | 2,131,325 | 5.49M |
| 116 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.04% | 489,432 | - |
| 117 | ZBIO | Zenas BioPharma, Inc. | 1.92B | 1.06% | 630,043 | 1.00M |
| 118 | DMRA | Damora Therapeutics, Inc. | 1.92B | 1.01% | 260,656 | - |
| 119 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -1.74% | 1,561,118 | 1.97B |
| 120 | NBTX | Nanobiotix S.A. | 1.90B | 0.37% | 238,331 | 38.27M |
| 121 | KARD | Kardigan, Inc. | 1.89B | -7.38% | 144,677 | - |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -1.82% | 249,331 | 1.13B |
| 123 | ZYME | Zymeworks Inc. | 1.78B | -2.48% | 332,532 | 37.13M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 3.98% | 1,251,100 | 252.25M |
| 125 | IMCR | Immunocore Holdings plc | 1.76B | 0.03% | 195,190 | 430.78M |
| 126 | AVLN | Avalyn Pharma Inc. | 1.74B | 7.30% | 193,374 | - |
| 127 | XNCR | Xencor, Inc. | 1.74B | 1.52% | 443,052 | 104.97M |
| 128 | BRVE | Braveheart Bio, Inc. | 1.73B | 4.08% | 330,008 | - |
| 129 | ANAB | AnaptysBio, Inc. | 1.73B | 4.37% | 330,819 | 232.39M |
| 130 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -4.53% | 10,545,071 | 54.86M |
| 131 | AAPG | Ascentage Pharma Group International | 1.69B | -1.32% | 185 | 82.08M |
| 132 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 0.68% | 2,360,909 | 59.51M |
| 133 | FTRE | Fortrea Holdings Inc. | 1.66B | -2.30% | 2,561,091 | 2.68B |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.61B | 2.75% | 479,905 | - |
| 135 | ABSI | Absci Corporation | 1.58B | -2.96% | 2,231,297 | 1.56M |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | 0.02% | 446,150 | - |
| 137 | JBIO | Jade Biosciences, Inc. | 1.57B | 3.78% | 1,478,343 | - |
| 138 | VIR | Vir Biotechnology, Inc. | 1.56B | 2.67% | 1,016,261 | 303.23M |
| 139 | LBRX | LB Pharmaceuticals Inc | 1.54B | 7.92% | 295,327 | - |
| 140 | INVA | Innoviva, Inc. | 1.53B | 2.12% | 448,805 | 440.00M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.51B | -1.77% | 230,636 | 20.00M |
| 142 | TYRA | Tyra Biosciences, Inc. | 1.51B | 1.08% | 420,518 | - |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.48B | -1.38% | 2,378,030 | 208.78M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.46B | -1.63% | 438,963 | - |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 1.09% | 828,503 | - |
| 146 | REPL | Replimune Group, Inc. | 1.40B | -1.45% | 2,398,900 | - |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.40B | -0.18% | 981,603 | - |
| 148 | AKTS | Aktis Oncology, Inc. | 1.39B | 4.79% | 229,625 | 10.06M |
| 149 | SVRA | Savara Inc. | 1.37B | 2.09% | 1,649,954 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.36B | -1.12% | 417,541 | - |
| 151 | NVAX | Novavax, Inc. | 1.33B | -1.11% | 2,279,529 | 413.80M |
| 152 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.15% | 509,489 | 28.73M |
| 153 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.72% | 314,739 | - |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 1.31B | 3.56% | 565,503 | - |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.30B | -8.91% | 268,188 | 1.30M |
| 156 | MGTX | MeiraGTx Holdings plc | 1.30B | 6.71% | 809,173 | 397.50M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.30B | 2.15% | 121,146 | - |
| 158 | IMTX | Immatics N.V. | 1.29B | -1.56% | 362,688 | 43.00M |
| 159 | EYPT | EyePoint, Inc. | 1.27B | 9.42% | 2,510,863 | 2.79M |
| 160 | APMD | Apnimed, Inc. | 1.26B | 10.28% | 650,927 | 120.15M |
| 161 | ANRO | Alto Neuroscience, Inc. | 1.26B | -0.50% | 874,487 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -1.65% | 777,869 | - |
| 163 | OMER | Omeros Corporation | 1.24B | -0.92% | 3,675,975 | 38.42M |
| 164 | MNKD | MannKind Corporation | 1.24B | 3.22% | 2,855,339 | 393.63M |
| 165 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | -2.84% | 303,585 | - |
| 166 | WVE | Wave Life Sciences Ltd. | 1.07B | 4.04% | 2,884,410 | 65.37M |
| 167 | SANA | Sana Biotechnology, Inc. | 1.06B | -3.27% | 3,705,707 | - |
| 168 | IVA | Inventiva S.A. | 1.06B | - | 573,820 | 7.94M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 0.72% | 388,066 | 59.00K |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 1,762,684 | 41.47M |
| 171 | ARDX | Ardelyx, Inc. | 1.01B | 3.84% | 3,978,332 | 450.89M |
| 172 | ANNX | Annexon, Inc. | 1.00B | 0.57% | 2,990,237 | - |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 993.35M | 0.05% | 136,326 | 99.00K |
| 174 | SLDB | Solid Biosciences Inc. | 986.47M | 1.32% | 759,399 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 985.52M | 0.75% | 441,506 | 24.00M |
| 176 | KURA | Kura Oncology, Inc. | 966.11M | 7.63% | 1,885,760 | 77.23M |
| 177 | GERN | Geron Corporation | 944.44M | -4.23% | 11,157,886 | 204.56M |
| 178 | CLYM | Climb Bio, Inc. | 937.93M | 10.86% | 2,498,136 | - |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 930.10M | 1.14% | 1,163,087 | - |
| 180 | DSGN | Design Therapeutics, Inc. | 928.09M | 3.06% | 259,838 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 923.95M | 1.97% | 1,438,696 | 181.72M |
| 182 | CADL | Candel Therapeutics, Inc. | 896.80M | -0.68% | 2,069,256 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 881.06M | 0.30% | 405,435 | 104.31M |
| 184 | SGP | SpyGlass Pharma, Inc. | 876.34M | 4.09% | 69,689 | - |
| 185 | ATTO | Attovia Therapeutics, Inc. | 854.56M | 3.55% | 98,155 | 1.35M |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 850.81M | -1.37% | 666,222 | 8.22M |
| 187 | FTH | Faeth Therapeutics, Inc. | 835.68M | 13.27% | 365,040 | - |
| 188 | SLN | Silence Therapeutics plc | 826.07M | -1.79% | 823,935 | 615.00K |
| 189 | PHAR | Pharming Group N.V. | 814.40M | -5.10% | 20,712 | 366.48M |
| 190 | DBVT | DBV Technologies S.A. | 810.62M | -0.07% | 128,541 | 5.04M |
| 191 | OCS | Oculis Holding AG | 798.81M | 0.94% | 125,378 | 1.45M |
| 192 | AURA | Aura Biosciences, Inc. | 797.49M | 0.52% | 684,461 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 795.39M | 4.39% | 223,974 | 276.79M |
| 194 | IMMX | Immix Biopharma, Inc. | 784.79M | 0.46% | 1,295,413 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 781.03M | 4.69% | 1,743,442 | - |
| 196 | OBX | Obsidian Therapeutics, Inc. | 769.91M | -6.08% | 32,771 | - |
| 197 | PHAT | Phathom Pharmaceuticals, Inc. | 760.94M | 4.36% | 968,846 | 239.66M |
| 198 | DRUG | Bright Minds Biosciences Inc. | 758.96M | -2.00% | 151,384 | - |
| 199 | MNPR | Monopar Therapeutics Inc. | 758.74M | 2.38% | 165,719 | - |
| 200 | STTK | Shattuck Labs, Inc. | 744.70M | 1.37% | 640,740 | 1.00M |
| 201 | HELP | Cybin Inc. | 743.19M | 4.72% | 1,524,729 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 733.61M | 3.07% | 229,860 | 11.88M |
| 203 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 0.30% | 1,433,000 | 18.30M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 725.77M | -1.84% | 227,475 | - |
| 205 | NGNE | Neurogene Inc. | 723.21M | 1.43% | 115,859 | 925.00K |
| 206 | RGNX | REGENXBIO Inc. | 710.63M | 0.98% | 792,486 | 174.48M |
| 207 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 2.14% | 52,735 | 109.82M |
| 208 | ALLO | Allogene Therapeutics, Inc. | 708.26M | 3.54% | 4,605,119 | 4.64M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 682.47M | 2.74% | 84,238 | - |
| 210 | FDMT | 4D Molecular Therapeutics, Inc. | 673.43M | 4.64% | 773,744 | 92.01M |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 672.22M | 1.25% | 777,759 | 136.07M |
| 212 | ASMB | Assembly Biosciences, Inc. | 670.88M | 10.02% | 559,104 | 74.85M |
| 213 | VALN | Valneva SE | 658.72M | 26.19% | 2,882,842 | 163.30M |
| 214 | SGMT | Sagimet Biosciences Inc. | 655.77M | 13.69% | 2,659,469 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 651.06M | -5.23% | 41,982 | - |
| 216 | MDXG | MiMedx Group, Inc. | 622.40M | 1.67% | 974,754 | 355.17M |
| 217 | NVCT | Nuvectis Pharma, Inc. | 617.75M | -1.40% | 106,659 | - |
| 218 | EIKN | Eikon Therapeutics, Inc. | 598.52M | 6.97% | 637,716 | - |
| 219 | VSTM | Verastem, Inc. | 595.91M | -1.35% | 1,279,892 | 87.53M |
| 220 | CRMD | CorMedix Inc. | 587.70M | -7.37% | 2,701,404 | 462.25M |
| 221 | ARVN | Arvinas, Inc. | 586.51M | -0.44% | 461,290 | 316.70M |
| 222 | AUTL | Autolus Therapeutics plc | 572.21M | -3.15% | 2,395,470 | 117.39M |
| 223 | ALT | Altimmune, Inc. | 571.88M | 2.08% | 3,073,959 | 31.00K |
| 224 | PRLD | Prelude Therapeutics Incorporated | 571.62M | 3.54% | 452,061 | 22.42M |
| 225 | SPRY | ARS Pharmaceuticals, Inc. | 561.88M | -7.38% | 5,045,919 | 116.93M |
| 226 | ARTV | Artiva Biotherapeutics, Inc. | 559.79M | 1.33% | 264,405 | 251.00K |
| 227 | OVID | Ovid Therapeutics Inc. | 552.69M | 1.07% | 1,240,940 | 1.58M |
| 228 | PRME | Prime Medicine, Inc. | 549.72M | -2.52% | 1,571,020 | 4.07M |
| 229 | MPLT | MapLight Therapeutics, Inc. | 544.94M | 1.47% | 451,766 | - |
| 230 | CTNM | Contineum Therapeutics, Inc. | 533.84M | -7.25% | 747,305 | - |
| 231 | ZURA | Zura Bio Limited | 533.77M | -1.07% | 793,483 | - |
| 232 | EVMN | Evommune, Inc. | 531.68M | 4.12% | 362,380 | 10.00M |
| 233 | ANL | Adlai Nortye Ltd. | 530.00M | 3.03% | 56,285 | 19.54M |
| 234 | CCCC | C4 Therapeutics, Inc. | 521.63M | 3.92% | 3,399,045 | 35.04M |
| 235 | RLMD | Relmada Therapeutics, Inc. | 512.02M | 1.05% | 925,427 | - |
| 236 | KYTX | Kyverna Therapeutics, Inc. | 505.26M | 1.11% | 579,854 | - |
| 237 | ENTX | Entera Bio Ltd. | 500.38M | 0.70% | 278,075 | 42.00K |
| 238 | BLSM | BlossomHill Therapeutics, Inc. | 495.81M | -1.04% | 323,931 | - |
| 239 | OABI | OmniAb, Inc. | 491.42M | -1.46% | 554,393 | 38.46M |
| 240 | RZLT | Rezolute, Inc. | 480.55M | - | 657,066 | - |
| 241 | CABA | Cabaletta Bio, Inc. | 466.25M | 1.48% | 2,352,224 | - |
| 242 | OCGN | Ocugen, Inc. | 457.80M | - | 2,978,231 | 4.58M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 457.24M | -6.22% | 1,451,274 | 132.42M |
| 244 | PBYI | Puma Biotechnology, Inc. | 455.81M | 1.38% | 233,031 | 231.24M |
| 245 | LRMR | Larimar Therapeutics, Inc. | 455.11M | 2.11% | 1,183,064 | - |
| 246 | PRTA | Prothena Corporation plc | 454.85M | -2.42% | 312,599 | 54.53M |
| 247 | QTTB | Q32 Bio Inc. | 451.01M | -1.43% | 313,004 | 53.74M |
| 248 | IKT | Inhibikase Therapeutics, Inc. | 438.80M | - | 227,863 | 1.00 |
| 249 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.27M | 0.75% | 162,959 | - |
| 250 | EDIT | Editas Medicine, Inc. | 433.10M | 0.36% | 1,478,023 | 47.01M |
| 251 | BNTC | Benitec Biopharma Inc. | 431.49M | - | 168,874 | - |
| 252 | SLBT | SL Science Holding Limited | 429.92M | -1.85% | 25,477 | 3.27M |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 418.40M | -1.63% | 840,931 | 15.85M |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 410.99M | -2.82% | 106,915 | 59.22M |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 410.65M | 0.99% | 250,010 | - |
| 256 | CMPX | Compass Therapeutics, Inc. | 405.20M | -0.44% | 1,362,088 | 850.00K |
| 257 | PROK | ProKidney Corp. | 402.09M | -5.34% | 1,415,365 | 818.00K |
| 258 | LXEO | Lexeo Therapeutics, Inc. | 397.09M | -2.42% | 676,670 | - |
| 259 | SCTX | Scribe Therapeutics Inc. | 391.06M | 1.77% | 118,844 | 36.28M |
| 260 | UPB | Upstream Bio, Inc. | 387.23M | 2.32% | 688,248 | 3.16M |
| 261 | CAPR | Capricor Therapeutics, Inc. | 386.62M | 57.96% | 66,332,872 | 11.13M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 383.29M | -2.08% | 173,405 | 65.26M |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 380.92M | 3.89% | 1,159,035 | - |
| 264 | VTVT | vTv Therapeutics Inc. | 374.23M | -2.37% | 74,826 | 36.84M |
| 265 | PALI | Palisade Bio, Inc. | 372.94M | -0.47% | 1,605,459 | 500.00K |
| 266 | FHTX | Foghorn Therapeutics Inc. | 371.75M | -3.54% | 139,956 | 36.74M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 360.22M | -1.04% | 165,172 | - |
| 268 | IPSC | Century Therapeutics, Inc. | 347.66M | -0.52% | 489,965 | 109.16M |
| 269 | GALT | Galectin Therapeutics Inc. | 346.92M | -2.55% | 388,190 | - |
| 270 | ABEO | Abeona Therapeutics Inc. | 342.25M | -5.75% | 5,445,166 | 25.52M |
| 271 | LYEL | Lyell Immunopharma, Inc. | 341.85M | 1.53% | 106,069 | 27.00K |
| 272 | CUVL | Clinuvel Pharmaceuticals Limited | 341.41M | 2.53% | 1,644 | 64.24M |
| 273 | CAMP | Camp4 Therapeutics Corporation | 341.38M | 20.89% | 426,581 | 4.22M |
| 274 | STRO | Sutro Biopharma, Inc. | 339.58M | -3.89% | 448,268 | 45.70M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 336.65M | -1.33% | 324,657 | 114.70K |
| 276 | VCRE | Vicore Pharma Holding AB (publ) | 331.56M | 5.12% | 32,526 | 370.61K |
| 277 | AGEN | Agenus Inc. | 329.55M | 4.57% | 1,251,853 | 132.69M |
| 278 | IMRX | Immuneering Corporation | 327.37M | -2.69% | 524,119 | - |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 315.62M | 3.78% | 965,067 | 215.72M |
| 280 | NMRA | Neumora Therapeutics, Inc. | 300.63M | -7.51% | 1,165,531 | - |
| 281 | IFRX | InflaRx N.V. | 300.63M | 1.49% | 1,468,286 | -11.54K |
| 282 | IRD | Opus Genetics, Inc. | 300.34M | -2.96% | 414,229 | 9.86M |
| 283 | FATE | Fate Therapeutics, Inc. | 299.56M | 1.98% | 1,995,011 | 6.49M |
| 284 | AVXL | Anavex Life Sciences Corp. | 298.40M | -1.53% | 698,059 | - |
| 285 | SION | Sionna Therapeutics, Inc. | 292.07M | -1.22% | 2,877,413 | - |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 287.95M | -4.32% | 1,341,458 | - |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 285.35M | 0.81% | 980,410 | 80.00M |
| 288 | TTRX | Turn Therapeutics Inc. | 285.07M | -2.94% | 98,203 | - |
| 289 | SRZN | Surrozen, Inc. | 281.62M | 0.97% | 212,865 | 11.51M |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 276.85M | 0.77% | 79,396 | 18.47M |
| 291 | BCYC | Bicycle Therapeutics plc | 272.97M | -2.01% | 468,117 | 61.21M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 271.02M | 1.03% | 584,160 | - |
| 293 | PRQR | ProQR Therapeutics N.V. | 270.95M | 3.78% | 487,193 | 21.05M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 270.61M | 0.94% | 1,129,345 | 13.08M |
| 295 | TRDA | Entrada Therapeutics, Inc. | 268.99M | 0.13% | 237,985 | 4.69M |
| 296 | MGNX | MacroGenics, Inc. | 268.58M | 3.43% | 851,433 | 175.14M |
| 297 | RNAC | Cartesian Therapeutics, Inc. | 267.46M | 1.38% | 86,398 | 1.48M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 265.06M | -0.90% | 142,765 | 31.98M |
| 299 | ZNTL | Zentalis Pharmaceuticals, Inc. | 255.15M | -14.22% | 4,575,450 | 26.87M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 254.26M | -4.70% | 274,478 | 7.15M |
| 301 | PYXS | Pyxis Oncology, Inc. | 251.06M | - | 703,830 | 11.04M |
| 302 | ACIU | AC Immune SA | 247.57M | -3.11% | 133,204 | 21.67M |
| 303 | GLSI | Greenwich LifeSciences, Inc. | 246.59M | 2.56% | 116,466 | - |
| 304 | ADAG | Adagene Inc. | 244.47M | -0.54% | 152,266 | 9.29M |
| 305 | NAGE | Niagen Bioscience, Inc. | 239.46M | -0.98% | 390,868 | 129.08M |
| 306 | CNXU | Conexeu Sciences Inc. | 238.15M | 11.67% | 245,299 | - |
| 307 | TARA | Protara Therapeutics, Inc. | 234.61M | 0.76% | 332,903 | - |
| 308 | ARCT | Arcturus Therapeutics Holdings Inc. | 233.92M | 4.71% | 930,679 | 29.37M |
| 309 | CLLS | Cellectis S.A. | 228.78M | -4.09% | 15,217 | 63.82M |
| 310 | CGEN | Compugen Ltd. | 228.29M | - | 191,226 | 74.00M |
| 311 | NBP | NovaBridge Biosciences | 226.67M | 3.16% | 333,539 | - |
| 312 | ANTX | AN2 Therapeutics, Inc. | 226.04M | 0.17% | 198,352 | - |
| 313 | RNA | Atrium Therapeutics, Inc. | 219.64M | 4.14% | 176,079 | 35.84M |
| 314 | ALEC | Alector, Inc. | 218.85M | -3.92% | 648,997 | 13.86M |
| 315 | IMUX | Immunic, Inc. | 218.76M | -3.14% | 79,542 | - |
| 316 | NERV | Minerva Neurosciences, Inc. | 218.68M | 16.84% | 340,693 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 217.99M | 1.68% | 347,538 | 29.10M |
| 318 | IVVD | Invivyd, Inc. | 212.49M | 5.13% | 2,030,018 | 58.37M |
| 319 | YDES | YD Bio Limited | 209.55M | 18.73% | 73,406 | 510.36K |
| 320 | PEPG | PepGen Inc. | 207.09M | 0.34% | 615,462 | - |
| 321 | VOGX | Vogenx, Inc. | 205.70M | 4.90% | 37,231 | - |
| 322 | DTIL | Precision BioSciences, Inc. | 205.08M | 1.78% | 142,104 | 45.06M |
| 323 | IPHA | Innate Pharma S.A. | 202.05M | -14.00% | 105,784 | 10.57M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 201.49M | 1.55% | 306,184 | 34.46M |
| 325 | MSLE | Satellos Bioscience Inc. | 200.85M | -2.14% | 37,597 | - |
| 326 | KROS | Keros Therapeutics, Inc. | 200.25M | -5.25% | 315,270 | 15.01M |
| 327 | KRRO | Korro Bio, Inc. | 195.56M | -0.08% | 47,072 | 2.38M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 195.15M | 0.10% | 425,832 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 193.09M | 4.71% | 526,682 | - |
| 330 | ACOG | Alpha Cognition Inc. | 192.48M | 2.43% | 247,591 | 15.26M |
| 331 | ORMP | Oramed Pharmaceuticals Inc. | 186.36M | 2.28% | 156,762 | 2.00M |
| 332 | CHRS | Coherus Oncology, Inc. | 185.40M | 5.26% | 648,327 | 50.94M |
| 333 | NGEN | NervGen Pharma Corp. | 184.63M | -1.42% | 562,864 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | -5.93% | 995,919 | 80.62M |
| 335 | MDWD | MediWound Ltd. | 175.06M | 0.22% | 46,748 | 11.86M |
| 336 | CDXS | Codexis, Inc. | 170.83M | -2.50% | 1,244,545 | 77.68M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 169.55M | -5.39% | 110,611 | 5.54M |
| 338 | CRBU | Caribou Biosciences, Inc. | 169.39M | -1.86% | 1,188,579 | 10.04M |
| 339 | HUMA | Humacyte, Inc. | 168.01M | 9.96% | 33,057,500 | 2.12M |
| 340 | NKTX | Nkarta, Inc. | 166.89M | 1.30% | 302,367 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 163.26M | -0.67% | 1,529,981 | 1.34M |
| 342 | OKUR | OnKure Therapeutics, Inc. | 161.58M | 2.31% | 216,704 | - |
| 343 | CNTN | Canton Strategic Holdings, Inc. | 160.96M | 2.54% | 747,914 | 1.50M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 160.58M | 0.39% | 212,178 | 2.95M |
| 345 | HURA | TuHURA Biosciences, Inc. | 157.30M | 7.39% | 317,088 | - |
| 346 | MOLN | Molecular Partners AG | 155.76M | - | 1,037 | 856.30K |
| 347 | KZIA | Kazia Therapeutics Limited | 154.49M | 2.35% | 142,765 | 1.27M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 153.48M | 2.04% | 768,180 | - |
| 349 | SPRB | Spruce Biosciences, Inc. | 151.29M | 5.77% | 42,133 | 697.00K |
| 350 | MENS | Jyong Biotech Ltd. | 149.95M | -1.94% | 21,090 | - |
| 351 | MIST | Milestone Pharmaceuticals Inc. | 149.66M | 2.80% | 2,167,023 | 2.34M |
| 352 | EQ | Equillium, Inc. | 149.21M | 17.41% | 538,707 | 4.39M |
| 353 | LENZ | LENZ Therapeutics, Inc. | 148.62M | 2.83% | 702,686 | 21.48M |
| 354 | TLSA | Tiziana Life Sciences Ltd | 146.76M | 9.13% | 991,858 | - |
| 355 | CUE | Cue Biopharma, Inc. | 143.65M | 10.04% | 157,300 | 32.73M |
| 356 | AARD | Aardvark Therapeutics, Inc. | 143.13M | 2.03% | 69,087 | - |
| 357 | OTLK | Outlook Therapeutics, Inc. | 141.44M | -14.90% | 104,623,239 | -1.16M |
| 358 | NRXP | NRx Pharmaceuticals, Inc. | 137.05M | -2.10% | 1,128,895 | 3.39M |
| 359 | CBUS | Cibus, Inc. | 135.11M | -6.84% | 331,903 | 4.35M |
| 360 | PMN | ProMIS Neurosciences, Inc. | 133.26M | 0.47% | 29,863 | - |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 123.09M | 4.00% | 148,298 | - |
| 362 | GNLX | Genelux Corporation | 121.68M | 4.18% | 462,787 | 8.00K |
| 363 | INDP | Indaptus Therapeutics, Inc. | 121.17M | 0.94% | 130,847 | - |
| 364 | VANI | Vivani Medical, Inc. | 120.73M | 4.48% | 114,345 | - |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 119.51M | 21.10% | 12,214,799 | 65.34K |
| 366 | YARW | Yarrow Bioscience, Inc. | 118.97M | -0.54% | 5,215 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 116.06M | - | 330,298 | 70.00M |
| 368 | SEER | Seer, Inc. | 115.06M | -0.95% | 126,365 | 14.22M |
| 369 | ENGN | enGene Therapeutics Inc. | 113.88M | 0.59% | 919,723 | - |
| 370 | NAUT | Nautilus Biotechnology, Inc. | 113.51M | 0.22% | 630,277 | 190.00K |
| 371 | COYA | Coya Therapeutics, Inc. | 112.36M | 2.57% | 113,556 | 8.02M |
| 372 | NTHI | NeOnc Technologies Holdings, Inc. | 109.44M | 31.46% | 646,475 | 39.99K |
| 373 | RANI | Rani Therapeutics Holdings, Inc. | 108.56M | -0.23% | 889,226 | 4.88M |
| 374 | GUTS | Fractyl Health, Inc. | 108.24M | 2.72% | 765,874 | 3.00K |
| 375 | ANIX | Anixa Biosciences, Inc. | 108.19M | -0.63% | 107,786 | - |
| 376 | TENX | Tenax Therapeutics, Inc. | 103.11M | -1.64% | 5,842,323 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 99.54M | 4.25% | 1,127,966 | - |
| 378 | FBIO | Fortress Biotech, Inc. | 97.72M | -1.68% | 1,031,522 | 68.47M |
| 379 | KLRS | Kalaris Therapeutics, Inc. | 97.07M | 5.15% | 28,090 | - |
| 380 | PYPD | PolyPid Ltd. | 96.28M | -0.84% | 59,945 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 96.04M | -2.88% | 509,455 | - |
| 382 | BMEA | Biomea Fusion, Inc. | 95.68M | 3.13% | 436,011 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 95.58M | -5.01% | 23,287 | 43.30M |
| 384 | ALDX | Aldeyra Therapeutics, Inc. | 94.11M | 8.33% | 830,972 | - |
| 385 | ICCC | ImmuCell Corporation | 90.92M | -7.80% | 92,024 | 30.68M |
| 386 | GANX | Gain Therapeutics, Inc. | 90.43M | -2.08% | 519,000 | - |
| 387 | RLYB | Rallybio Corporation | 90.23M | 0.18% | 12,920 | 646.00K |
| 388 | ACET | Adicet Bio, Inc. | 90.21M | 1.45% | 57,913 | - |
| 389 | VRCA | Verrica Pharmaceuticals Inc. | 85.38M | 2.26% | 59,631 | 30.32M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 85.16M | 4.48% | 569,026 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 84.04M | 1.91% | 7,457 | 4.43M |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 83.46M | 5.41% | 758,082 | - |
| 393 | ELTX | Elicio Therapeutics, Inc. | 81.21M | -1.90% | 155,519 | - |
| 394 | OKYO | OKYO Pharma Limited | 79.77M | 0.66% | 65,018 | - |
| 395 | ANVS | Annovis Bio, Inc. | 78.70M | 3.35% | 949,712 | - |
| 396 | NRXS | NeurAxis, Inc. | 78.02M | 0.32% | 54,026 | 5.32M |
| 397 | ELOX | Eloxx Pharmaceuticals, Inc. | 75.72M | -1.63% | 29,638 | - |
| 398 | GOSS | Gossamer Bio, Inc. | 75.38M | -9.45% | 13,855,953 | 53.29M |
| 399 | TELO | Telomir Pharmaceuticals, Inc. | 74.96M | 3.81% | 58,441 | - |
| 400 | LONA | LeonaBio, Inc. | 74.82M | 1.21% | 9,290 | - |
| 401 | ATRA | Atara Biotherapeutics, Inc. | 72.89M | -4.94% | 66,247 | 6.19M |
| 402 | DWTX | Dogwood Therapeutics, Inc. | 72.30M | 8.59% | 105,790 | - |
| 403 | OSTX | OS Therapies Incorporated | 72.15M | 1.25% | 401,744 | - |
| 404 | SPRO | Spero Therapeutics, Inc. | 71.22M | -0.81% | 744,543 | 47.00M |
| 405 | IBIO | iBio, Inc. | 71.04M | 2.14% | 522,573 | 300.00K |
| 406 | CSBR | Champions Oncology, Inc. | 70.37M | -0.30% | 26,338 | 59.43M |
| 407 | XBIT | XBiotech Inc. | 70.12M | -1.29% | 46,497 | - |
| 408 | RNTX | Rein Therapeutics Inc. | 68.94M | 2.35% | 216,067 | - |
| 409 | CING | Cingulate Inc. | 68.56M | 2.00% | 207,724 | - |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 67.20M | 3.70% | 189,816 | - |
| 411 | IMA | ImageneBio, Inc. | 66.29M | -0.51% | 3,286 | 800.00K |
| 412 | PLRX | Pliant Therapeutics, Inc. | 66.25M | -0.93% | 235,026 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 66.25M | 1.44% | 99,096 | 11.43M |
| 414 | CRDF | Cardiff Oncology, Inc. | 65.84M | -2.13% | 481,300 | 508.00K |
| 415 | MNOV | MediciNova, Inc. | 64.48M | - | 45,057 | 920.48K |
| 416 | BOLD | Boundless Bio, Inc. | 64.37M | 1.98% | 108,950 | - |
| 417 | HRTX | Heron Therapeutics, Inc. | 63.92M | 0.69% | 1,762,099 | 151.18M |
| 418 | RNXT | RenovoRx, Inc. | 63.14M | 11.11% | 1,007,048 | 1.98M |
| 419 | INMB | INmune Bio Inc. | 60.23M | 4.33% | 461,663 | 50.00K |
| 420 | BSEM | BioStem Technologies, Inc. | 56.90M | 3.55% | 104,404 | 91.15M |
| 421 | INKT | MiNK Therapeutics, Inc. | 56.15M | 2.45% | 6,787 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 54.86M | 1.78% | 8,113 | 64.09M |
| 423 | ATYR | aTyr Pharma, Inc. | 54.83M | 1.08% | 656,608 | 190.00K |
| 424 | IMMP | Immutep Limited | 54.33M | -5.82% | 66,756 | 5.28M |
| 425 | ALPS | Alps Group Inc | 53.25M | -2.44% | 74,679 | 3.74M |
| 426 | EXOZ | eXoZymes, Inc. | 53.02M | -3.00% | 9,086 | -700.00 |
| 427 | EDSA | Edesa Biotech, Inc. | 51.54M | -1.47% | 45,909 | - |
| 428 | APLM | Apollomics, Inc. | 51.39M | 34.72% | 47,734 | 8.84M |
| 429 | MREO | Mereo BioPharma Group plc | 50.90M | 3.64% | 1,850,634 | 500.00K |
| 430 | TCRX | TScan Therapeutics, Inc. | 50.90M | 0.88% | 278,387 | 7.11M |
| 431 | TIL | Instil Bio, Inc. | 50.05M | 1.51% | 13,524 | - |
| 432 | IBO | Impact BioMedical Inc. | 49.52M | 4.39% | 51,126 | 35.00K |
| 433 | CNTX | Context Therapeutics Inc. | 48.04M | 3.26% | 1,263,848 | - |
| 434 | VRXA | Veraxa Biotech AG | 47.16M | -1.06% | 187,947 | - |
| 435 | VERU | Veru Inc. | 46.55M | 1.11% | 159,021 | 16.89M |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 46.47M | - | 83,491 | 13.56M |
| 437 | KPTI | Karyopharm Therapeutics Inc. | 45.82M | 1.51% | 886,722 | 146.62M |
| 438 | GRCE | Grace Therapeutics, Inc. | 45.44M | 4.35% | 397,770 | - |
| 439 | MCRB | Seres Therapeutics, Inc. | 45.13M | 1.34% | 37,280 | 1.88M |
| 440 | FLNA | Filana Therapeutics, Inc. | 44.12M | -3.45% | 291,713 | - |
| 441 | ALGS | Aligos Therapeutics, Inc. | 43.03M | 1.77% | 66,721 | 31.52M |
| 442 | SER | Serina Therapeutics, Inc. | 41.99M | -1.75% | 75,970 | 130.00K |
| 443 | CRVO | CervoMed Inc. | 41.28M | -6.83% | 608,452 | 331.30K |
| 444 | HYPD | Hyperion DeFi, Inc. | 41.23M | -3.89% | 157,524 | 1.40M |
| 445 | NTRB | Nutriband Inc. | 40.11M | 3.45% | 4,156 | 1.80M |
| 446 | NXTC | NextCure, Inc. | 37.58M | -0.85% | 262,004 | - |
| 447 | BYSI | BeyondSpring Inc. | 34.50M | -15.78% | 784,971 | 1.88M |
| 448 | RADX | Radiopharm Theranostics Limited | 33.82M | -3.40% | 79,344 | 10.86M |
| 449 | LTRN | Lantern Pharma Inc. | 33.81M | 0.76% | 165,491 | - |
| 450 | QNCX | Quince Therapeutics, Inc. | 33.29M | 5.03% | 25,913 | - |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 32.70M | 7.90% | 490,513 | 35.09M |
| 452 | NNVC | NanoViricides, Inc. | 31.44M | 1.47% | 205,726 | - |
| 453 | ESLA | Estrella Immunopharma, Inc. | 31.12M | -0.19% | 9,009 | - |
| 454 | GNTA | Genenta Science S.p.A. | 30.67M | - | 26,008 | - |
| 455 | LITS | Lite Strategy, Inc. | 30.16M | -1.01% | 80,756 | - |
| 456 | IGC | IGC Pharma, Inc. | 29.81M | 1.29% | 1,541,219 | 1.11M |
| 457 | BCTX | BriaCell Therapeutics Corp. | 29.65M | - | 40,490 | - |
| 458 | GRDX | GridAI Technologies Corp. | 29.53M | 10.03% | 311,554 | - |
| 459 | TVGN | Tevogen Inc. | 28.99M | 4.57% | 8,214 | - |
| 460 | KYNB | Kyntra Bio, Inc. | 28.54M | 0.14% | 17,701 | 4.62M |
| 461 | DYAI | Dyadic International, Inc. | 28.24M | 0.65% | 164,342 | 3.80M |
| 462 | EVAX | Evaxion A/S | 27.86M | 4.02% | 19,821 | 7.53M |
| 463 | ENLV | Enlivex Ltd. | 27.63M | -6.51% | 342,197 | - |
| 464 | CVM | CEL-SCI Corporation | 26.91M | 3.36% | 218,400 | - |
| 465 | JSPR | Jasper Therapeutics, Inc. | 26.24M | -8.46% | 569,240 | - |
| 466 | ATOS | Atossa Therapeutics, Inc. | 25.95M | 1.56% | 96,103 | - |
| 467 | CNSY | Cerenome, Inc. | 25.33M | -0.54% | 109,006 | 4.20M |
| 468 | QNTM | Quantum BioPharma Ltd. | 24.48M | 17.65% | 277,303 | - |
| 469 | ACTU | Actuate Therapeutics, Inc. | 24.17M | 3.58% | 109,712 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 24.14M | -1.48% | 28,607 | 14.97M |
| 471 | LGVN | Longeveron Inc. | 23.38M | 6.06% | 298,765 | 1.19M |
| 472 | ABVC | ABVC BioPharma, Inc. | 22.74M | -6.20% | 116,868 | 797.92K |
| 473 | ALLR | Allarity Therapeutics, Inc. | 21.80M | 0.74% | 48,145 | 345.00K |
| 474 | COCP | Cocrystal Pharma, Inc. | 21.57M | 1.82% | 38,296 | 330.00K |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 20.92M | 1.04% | 23,708 | -13.27K |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.78M | 4.84% | 46,332 | - |
| 477 | CTXR | Citius Pharmaceuticals, Inc. | 20.74M | 3.00% | 688,958 | 7.11M |
| 478 | PLRZ | Polyrizon Ltd. | 20.55M | 2.14% | 63,735 | - |
| 479 | CELU | Celularity Inc. | 20.14M | 0.07% | 11,412 | 26.55M |
| 480 | HOWL | Werewolf Therapeutics, Inc. | 19.67M | 4.84% | 274,408 | 21.00M |
| 481 | MRKR | Marker Therapeutics, Inc. | 19.01M | 2.70% | 45,558 | 3.55M |
| 482 | NCEL | NewcelX Ltd. | 18.01M | -7.08% | 46,833 | - |
| 483 | TVRD | Tvardi Therapeutics, Inc. | 17.82M | 7.34% | 355,671 | - |
| 484 | SKYE | Skye Bioscience, Inc. | 17.62M | -7.30% | 6,604,361 | - |
| 485 | KALA | KALA BIO, Inc. | 17.58M | 2.33% | 32,178 | - |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 17.46M | -3.07% | 24,204 | 1.90M |
| 487 | PTN | Palatin Technologies, Inc. | 17.44M | -6.40% | 12,333 | 12.88M |
| 488 | LPCN | Lipocine Inc. | 17.40M | 2.43% | 31,386 | 1.57M |
| 489 | PLUR | Pluri Inc. | 17.26M | -3.67% | 2,989 | 1.08M |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 16.75M | 2.26% | 55,517 | - |
| 491 | TPST | Tempest Therapeutics, Inc. | 16.22M | -13.25% | 435,155 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 16.06M | 0.52% | 43,253 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.30M | 2.78% | 6,140 | 129.73K |
| 494 | MLEC | Moolec Science SA | 14.98M | 3.00% | 661 | 7.83M |
| 495 | LEXX | Lexaria Bioscience Corp. | 14.94M | 11.60% | 15,759 | 194.00K |
| 496 | PASG | Passage Bio, Inc. | 14.77M | 0.33% | 2,203 | - |
| 497 | SNTI | Senti Biosciences Holdings, Inc. | 13.98M | 16.93% | 608,600 | 38.00K |
| 498 | DARE | Daré Bioscience, Inc. | 13.93M | -32.12% | 8,087,945 | 1.37M |
| 499 | CMMB | Chemomab Therapeutics Ltd. | 13.75M | 0.53% | 21,296 | - |
| 500 | BLRX | BioLineRx Ltd. | 13.30M | 1.51% | 3,075 | 1.40M |